Myocardial Infarction D009203

Related MeSH Hierarchy (4)

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Myocardial Ischemia » Myocardial Infarction

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Myocardial Ischemia » Myocardial Infarction

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Ischemia » Infarction » Myocardial Infarction

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Necrosis » Infarction » Myocardial Infarction

Description

NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).   MeSH

Subtype Terms (6)

MINOCA
5 approved drugs

Non-ST Elevated Myocardial Infarction
21 drugs (20 approved, 1 experimental)

Shock, Cardiogenic
27 drugs (20 approved, 7 experimental)

ST Elevation Myocardial Infarction
83 drugs (59 approved, 24 experimental)


Phase 4 Indicated Drugs (87)


Organization Involved with Phase 4 Indications (238)

Aalborg University

Aarhus University

Aarne Koskelo Foundation

Academy of Athens

Allegheny Health Network

Amylin

A.R. CARD Onlus Foundation

Athens Red Cross Hospital

Azienda Sanitaria Ospedaliera

B. Braun

Beijing Bozhiyin T&S Co., Ltd.

Ben Gurion University

Boehringer Ingelheim

Boston Scientific Corporation

Bristol-Myers Squibb

Byrraju Foundation

Campus Bio-Medico University

Canadian Institutes of Health Research (CIHR)

Cancer Research Network

Capital Medical University

Catholic University of Sacred Heart, Rome

Central Denmark Region

Central South University

Charles University

Chiesi

China Medical University

China Resources Zizhu Pharmaceutical Co., Ltd.

Chinese Academy of Medical Sciences

CHINESE ARMED POLICE FORCE GENRAL HOSPITAL

Chinese Center of Diseases Control and Prevention

Chonbuk National University

Chonnam National University

Chungnam National University

CLI Foundation

Compusense Oegstgeest

Cordis

Croatian Science Foundation

Dalian Medical University

Dammam Central Hospital

Danish Heart Foundation

Department of Veteran Affairs

Dong-A University

Edwards Lifesciences

Eli Lilly

Erasmus University Rotterdam

Evangelismos Hospital

Federal University of Rio Grande do Sul

Finnish Foundation for Cardiovascular Research

Florida Atlantic University

Fondo de Investigacion Sanitaria

Free University of Amsterdam

Fudan University

Fundacja Ośrodek Badań Medycznych

Fund for Clinical Cardiovascular Research at LRD

Gelderse Vallei Hospital

Gelre Hospitals

Genentech

General Hospital of Chinese Armed Police Forces

Gennimatas Hospital, Athens

GlaxoSmithKline

Government of China

Government of Czech Republic

Government of Spain

Green Valley Group of China

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou Recomgen Biotech Co., Ltd.

Guangzhou University

Guidant Corporation

Gyeongsang University

Hamilton Health Sciences Corporation

Harvard University

Huazhong University of Science and Technology

Icahn School of Medicine at Mount Sinai

Imam Abdulrahman Bin Faisal University

Imperial College London

Inha University

Inova Health System

Instituto Dante Pazzanese de Cardiologia

Instituto Mexicano del Seguro Social

Intermountain Health Care

Intermountain Heart Institute

Isala Clinics, Zwolle, The Netherlands

Istanbul University

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Clinico Sant'Ambrogio

ISU ABXIS

Japan Heart Foundation

Jiao Tong University

Jinan University

Karolinska Institute

Katholieke Universiteit Leuven

King Fahad Armed Forces Hospital

Kobe University

Korean Society of Interventional Cardiology

Korea University

Krakowskie Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii Carint Scanmed Sp. z o.o

Kumamoto University

Kyoto Prefectural University of Medicine

Kyoto University

Kyung Hee University

Kyungpook University

Lantheus Medical Imaging

Laval University

Leiden University

LifeBridge Health

Life Sciences Research Partners

Lund University

Lytics

Maastricht University

McMaster University

Meander Medical Center

Medical Center Leeuwarden

Medical Center of South Arkansas

Medical University of Warsaw

Medisch Spectrum Twente

Medtronic

Melbourne Health

Mid America Heart Institute

Misericordia and Dolce Hospital

Mochida Pharmaceutical Company, Ltd.

Nanjing Medical University

National Health and Medical Research Council, Australia

National Heart, Lung, and Blood Institute (NHLBI)

National University of Singapore

New York University

Nicolaus Copernicus University

Noordwest Ziekenhuisgroep

Norra Alvsborgs Lans Hospital, Trollhattan

Norwegian University of Science and Technology

Novo Nordisk

Orebro University

Orion Corporation

Osaka Acute Coronary Insufficiency Study Group

Osaka General Medical Center

Osaka University

Ospedale della Misericordia - Grosseto

Ospedale Maggiore, Novara

Ospedale Misericordia e Dolce, Prato

Otsuka

Peking University

Penza State University

People's Liberation Army of China

Platelet and Thrombosis Research L.L.C

Pusan National University

R&D Cardiologie

Regeneron

Region of Southern Denmark

Region Örebro County

Region Skane

Region Zealand

Rijnstate Hospital

Saint Luke's Health System

Schulz Foundation

Seoul National University

Shanghai Xuhui District Central Hospital

Sheffield Hallam University

SHF Svendborg

Silesian University of Medicine

Southeast University

Spanish Society of Cardiology

St. Antonius Hospital, Nieuwegein

Stockholm South General Hospital

Sungkyunkwan University

Swedish Heart Lung Foundation

Taichung Veterans General Hospital

Teaching Hospital Královské Vinohrady (FNKV)

Technical University of Munich

Technion University

Tel Aviv University

Temple University

The Baruch Padeh Medical Center, Poriya

The Capital Region of Denmark

The Future Forum, UK

The North Denmark Region

The Royal Wolverhampton NHS Trust

The Swedish Research Council

The TIMI Study Group

The University of Hong Kong

Tsinghua University

Universidad Carlos III Madrid

Organization Involved with Phase 3 Indications (214)

Abbott

Action Research Group

American Society of Nephrology

Amgen

Anthropometrics Heart Clinic

ARTTIC International Management Services

ARYx Therapeutics

AtheroGenics

Atlantic Health System

Axio Research Corporation

Baqiyatallah Medical Sciences University

Basildon and Thurrock University Hospitals NHS Foundation Trust

Baylor University

Bharat Biotech International Limited

Binawaluya Cardiac Hospital

Bioheart, Inc.

Bio-Science Laboratories

Boston Health and Hospitals Department

Boston University

Brazilian Clinical Research Institute

British Heart Foundation

Canadian Heart Research Centre

Canadian VIGOUR Centre

CardioVascular Research Foundation, Korea

Cardiovascular Research Foundation, New York

Cayetano Heredia University

Centers for Disease Control and Prevention (CDC)

Centocor

Central Army Hospital RSPAD Gatot Soebroto

Chiangmai University

Chinese People's Armed Police Forces

CHU Henri Mondor

Clinical Centre of Serbia

Clinical Hospital #15 Clinical Hospital #15 named after O.M.Filatov, Moscow, Russia

Cogentus Pharmaceuticals

Columbia University

Cornell University

Daiichi Sankyo

Dartmouth University

Dexa Medica Group

Duke University

Emory University

Eurofarma Laboratorios S.A.

FCB-Pharmicell Co Ltd.

Ferrer Internacional S.A.

Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus

Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway

French Cardiology Society

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fundacion Investigacion Interhospitalaria Cardiovascular

Geisinger Clinic

Georgetown University

George Washington University

Government of Mexico

Government of Norway

Government of Poland

Greater Baltimore Medical Center

Hamad Medical Corporation

Health Care Centers of Illinois

Heart and Stroke Foundation of Canada

Heart Care Foundation

Hebrew University

HEINZ NIXDORF-FOUNDATION

Hellenic Cardiovascular Research Society

Henry Ford Health System

Hippocrates Research

Hospital Alessandro Manzoni Lecco

Hospital do Coracao

Hospital e Maternidade Celso Pierro

Hospital General Universitario Gregorio Marañon

Hospital Universitario Virgen Macarena

Humboldt University

IHF GmbH - Institut für Herzinfarktforschung

Institute of Cardiology, Tomsk, Russia

Institut National de la Santé Et de la Recherche Médicale, France

Instituto de Ciencias del Corazon

Investigación Independiente S.A.

IRW Consulting

Isfahan University

Iuliu Hatieganu University of Medicine and Pharmacy

John Paul II Hospital, Krakow

Johnson and Johnson

J. W. Goethe University

JW Pharmaceutical

Kaiser Foundation

Kennedy-Leigh charitable trust

Kepler University

Kosuyolu Heart Hospital

Landeskrankenhaus Feldkirch

Lankenau Hospital

Linkoping University

Ludwig Maximilians University

Maimonides Medical Center

Mario Negri Institute

Maryland Medical Research Institute

Mayo Clinic

McGill University

Medical College of Virginia

Medical Research Council

Medical University of Graz

Medicure

Miami Heart Institute

Mt. Sinai Medical Center, Miami

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institutes of Health (NIH)

New England Research Institutes

New York Medical College

North Sichuan Medical University

Northwell Health

Northwestern University

Norwegian Heart and Lung Patient Organisation

Ogden Research Foundation

Pacific Health Research Institute

Palo Alto Medical Research Foundation

Paracelsus Medical University

Pharmacia & Upjohn

Prairie Vascular Research Inc.

Prairie Vascular Research Network, Regina, Saskatchewan

Procter and Gamble

Pronova BioPharma

Rhode Island Hospital

Roche

Romania:The National Authority for Scientific Research

Royan Institute

Rusculleda Foundation Instituto DAMIC

Rush University

Russian Academy of Medical Sciences

Rutgers University

Salt Lake Clinic Research Foundation

San Carlos University Hospital, Madrid

Santa Rosa Medical Center

Schering-Plough

SCRI Development Innovations

Semmelweis University

Shenzhen Salubris Pharmaceuticals Co., Ltd.

South Australian Health and Medical Research Institute

Spartan Bioscience Inc.

State University of New York

Stiftung Institut fuer Herzinfarktforschung

St. Joseph Hospital Health Center

St. Louis University

Suleyman Demirel University

Supergene, LLC

Suzhou Landing Pharmaceuticals

Swedish Foundation for Strategic Research

Takeda

Teikyo University

Texas Tech University

Thailand Research Fund

The Society of Cardiac Health Protection

The University of Texas, Dallas

Thrombolysis in Myocardial Infarction Study Group

TIMI Study Group, Boston, MA

Trommsdorff GmbH & Co. KG

Tufts University

United Arab Emirates University

United States Army

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

University of Aberdeen

Organization Involved with Phase 2 Indications (118)

Organization Involved with Other Experimental Indications (58)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.